Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Shares withheld for taxes President and CEO gave up 2,678 shares (to pay taxes)
  2. 4 Shares withheld for taxes Vice President and CFO gave up 507 shares (to pay taxes)
  3. 4 Grant or award Director acquired 1,991 shares (grant or award)
  4. 4 Grant or award Director acquired 1,991 shares (grant or award)
  5. 4 Grant or award SVP Ops & Prod Dev acquired 6,848 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 37,280 shares (grant or award)
  7. 4 Grant or award Vice President and CFO acquired 12,451 shares (grant or award)
  8. 4 Grant or award Director acquired 1,991 shares (grant or award)
  9. 4 Grant or award Director acquired 2,584 shares (grant or award)
  10. 4 Grant or award SVP - New Bus Dev & Spec Sales acquired 12,451 shares (grant or award)
  11. 4 Grant or award Director acquired 1,991 shares (grant or award)
  12. 4 Open-market sale President and CEO sold 27,625 shares at an average $63.53 ($1,754,960)
  13. 4 Open-market sale SVP - New Bus Dev & Spec Sales sold 11,796 shares at an average $64.44 ($760,168)
  14. 5 Insider Annual Insider Trading Report
  15. 4 Exercise or conversion SVP - New Bus Dev & Spec Sales acquired 28,688 shares (option exercise)
  16. 4 Grant or award Director acquired 1,800 shares (grant or award)
  17. 4 Grant or award Director acquired 1,800 shares (grant or award)
  18. 4 Grant or award Director acquired 1,800 shares (grant or award)
  19. 4 Grant or award Director acquired 1,200 shares (grant or award)
  20. 4 Grant or award Director acquired 1,200 shares (grant or award)

Page 21 of 42 · 835 filings